BLUTFLUSSBEGRENZER FÜR KARDIOVASKULÄRE BEHANDLUNG

Patent europeic · EP3373828 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3373828
Numer da la dumonda
EP16790692
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
27-09-2016
Publitgà
19-09-2018
Concedì
10-12-2025
La protecziun finescha il pli tard
26-09-2036
Proxima taxa annuala scadenta
30-09-2026
Classas IPC
A61B 17/12 (2006.01)
A61B 90/00 (2016.01)
Prioritad
US 201562252599 P 09.11.2015
Dumonda PCT
PCT/IB2016/055763 27.09.2016
Publicaziun PCT
WO2017/081561 18.05.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-10-2026

    Midada

    Published in Swissreg on 21.10.2026

  2. 10-12-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 10.12.2025

Partidas

Possessur

Revamp Medical Ltd.

21 Habarzel Street, 6971029 Tel Aviv, IL

Inventur

TAL, Michael G

5652517 Savyon, IL

AVITOV, Lihu

6905023 Tel Aviv, IL

BENARY, Raphael

6949412 Tel Aviv, IL

SHOHAT, Yael

4633056 Herzliya, IL

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.